Weiqi Pan
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Viral gastroenteritis research and epidemiology 9
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 3
- Epidemiology 27
- Influenza Virus Research Studies 24
- Respiratory viral infections research 15
Weiqi Pan
38 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Infectious Diseases 501
- Pharmacology 205
- Complementary and alternative medicine 193
- Epidemiology 340
- Immunology 202
Countries citing papers authored by Weiqi Pan
This map shows the geographic impact of Weiqi Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqi Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqi Pan more than expected).
Fields of papers citing papers by Weiqi Pan
This network shows the impact of papers produced by Weiqi Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqi Pan. The network helps show where Weiqi Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiqi Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 1 | |
| 12 | Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Hit paper breakdown → | 2020 | 495 |
| 13 | 2020 | 84 | |
| 14 | 2020 | 8 | |
| 15 | 2017 | 19 | |
| 16 | 2014 | 13 | |
| 17 | 2013 | 6 | |
| 18 | 2011 | 56 | |
| 19 | 2010 | 13 | |
| 20 | 2010 | 4 |
About Weiqi Pan
Weiqi Pan is a scholar working on Infectious Diseases, Epidemiology, Animal Science and Zoology, Virology and Immunology, having authored 41 papers that have together received 1.3k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (24 papers), Respiratory viral infections research (15 papers), Viral gastroenteritis research and epidemiology (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Animal Virus Infections Studies (5 papers), interferon and immune responses (4 papers), COVID-19 Clinical Research Studies (3 papers) and Animal Disease Management and Epidemiology (3 papers). The work is most often cited by research in Infectious Diseases (501 citations), Pharmacology (205 citations), Complementary and alternative medicine (193 citations), Epidemiology (340 citations) and Immunology (202 citations). Weiqi Pan has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Chufang Li, Ling Chen, Zifeng Yang, Jun Dai, Jicheng Huang, Kui Zheng, Haiming Jiang, Yongxia Shi, Runfeng Li and Qinhai Ma. Their work appears in journals such as Antiviral Research, Journal of Virology, Pharmacological Research, Vaccines and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.